Beacon Investment Advisory Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$565K Buy
8,087
+637
+9% +$44.5K 0.02% 163
2025
Q1
$548K Buy
7,450
+439
+6% +$32.3K 0.03% 159
2024
Q4
$459K Buy
7,011
+11
+0.2% +$721 0.02% 173
2024
Q3
$545K Sell
7,000
-19
-0.3% -$1.48K 0.02% 169
2024
Q2
$547K Buy
7,019
+19
+0.3% +$1.48K 0.02% 168
2024
Q1
$474K Hold
7,000
0.02% 181
2023
Q4
$471K Hold
7,000
0.02% 185
2023
Q3
$474K Hold
7,000
0.02% 194
2023
Q2
$501K Hold
7,000
0.02% 196
2023
Q1
$486K Hold
7,000
0.02% 189
2022
Q4
$475K Hold
7,000
0.02% 190
2022
Q3
$384K Hold
7,000
0.02% 204
2022
Q2
$462K Sell
7,000
-158
-2% -$10.4K 0.02% 198
2022
Q1
$474K Sell
7,158
-110
-2% -$7.28K 0.02% 213
2021
Q4
$423K Buy
7,268
+110
+2% +$6.4K 0.02% 227
2021
Q3
$430K Sell
7,158
-80
-1% -$4.81K 0.02% 220
2021
Q2
$434K Sell
7,238
-256
-3% -$15.4K 0.02% 221
2021
Q1
$373K Sell
7,494
-975
-12% -$48.5K 0.02% 228
2020
Q4
$423K Sell
8,469
-2,835
-25% -$142K 0.02% 199
2020
Q3
$619K Buy
11,304
+555
+5% +$30.4K 0.03% 163
2020
Q2
$569K Buy
10,749
+3,404
+46% +$180K 0.03% 161
2020
Q1
$328K Hold
7,345
0.02% 186
2019
Q4
$366K Buy
7,345
+345
+5% +$17.2K 0.02% 204
2019
Q3
$312K Hold
7,000
0.03% 193
2019
Q2
$289K Sell
7,000
-10,000
-59% -$413K 0.03% 190
2019
Q1
$687K Sell
17,000
-490
-3% -$19.8K 0.07% 125
2018
Q4
$664K Sell
17,490
-41
-0.2% -$1.56K 0.07% 137
2018
Q3
$694K Sell
17,531
-6,949
-28% -$275K 0.07% 131
2018
Q2
$859K Sell
24,480
-268
-1% -$9.4K 0.09% 123
2018
Q1
$865K Buy
24,748
+3,400
+16% +$119K 0.09% 124
2017
Q4
$741K Sell
21,348
-6,914
-24% -$240K 0.08% 128
2017
Q3
$957K Buy
28,262
+20,318
+256% +$688K 0.08% 131
2017
Q2
$271K Buy
7,944
+373
+5% +$12.7K 0.05% 91
2017
Q1
$236K Buy
7,571
+54
+0.7% +$1.68K 0.05% 75
2016
Q4
$205K Buy
7,517
+55
+0.7% +$1.5K 0.04% 71
2016
Q3
$245K Buy
7,462
+326
+5% +$10.7K 0.05% 61
2016
Q2
$215K Hold
7,136
0.05% 65
2016
Q1
$201K Buy
7,136
+225
+3% +$6.34K 0.04% 60
2015
Q4
$235K Hold
6,911
0.04% 56
2015
Q3
$220K Buy
+6,911
New +$220K 0.04% 57